The presenting symptom signatures of incident cancer: evidence from the English 2018 National Cancer Diagnosis Audit.

Autor: Zakkak N; Epidemiology of Cancer Healthcare and Outcomes (ECHO) Group, Department of Behavioural Science and Health, Institute of Epidemiology and Health Care, University College London, London, UK. nadine.zakkak@ucl.ac.uk., Barclay ME; Epidemiology of Cancer Healthcare and Outcomes (ECHO) Group, Department of Behavioural Science and Health, Institute of Epidemiology and Health Care, University College London, London, UK., Swann R; National Disease Registration Service, NHS England, London, UK.; Cancer Intelligence, Cancer Research UK, London, UK., McPhail S; National Disease Registration Service, NHS England, London, UK., Rubin G; Population Health Sciences Institute, Newcastle University, Newcastle Upon Tyne, UK., Abel GA; Medical School, College of Medicine and Health, University of Exeter, St Luke's Campus, Heavitree Road, Exeter, London, UK., Lyratzopoulos G; Epidemiology of Cancer Healthcare and Outcomes (ECHO) Group, Department of Behavioural Science and Health, Institute of Epidemiology and Health Care, University College London, London, UK.
Jazyk: angličtina
Zdroj: British journal of cancer [Br J Cancer] 2024 Feb; Vol. 130 (2), pp. 297-307. Date of Electronic Publication: 2023 Dec 06.
DOI: 10.1038/s41416-023-02507-4
Abstrakt: Background: Understanding relationships between presenting symptoms and subsequently diagnosed cancers can inform symptom awareness campaigns and investigation strategies.
Methods: We used English National Cancer Diagnosis Audit 2018 data for 55,122 newly diagnosed patients, and examined the relative frequency of presenting symptoms by cancer site, and of cancer sites by presenting symptom.
Results: Among 38 cancer sites (16 cancer groups), three classes were apparent: cancers with a dominant single presenting symptom (e.g. melanoma); cancers with diverse presenting symptoms (e.g. pancreatic); and cancers that are often asymptomatically detected (e.g. chronic lymphocytic leukaemia). Among 83 symptoms (13 symptom groups), two classes were apparent: symptoms chiefly relating to cancers of the same body system (e.g. certain respiratory symptoms mostly relating to respiratory cancers); and symptoms with a diverse cancer site case-mix (e.g. fatigue). The cancer site case-mix of certain symptoms varied by sex.
Conclusion: We detailed associations between presenting symptoms and cancer sites in a large, representative population-based sample of cancer patients. The findings can guide choice of symptoms for inclusion in awareness campaigns, and diagnostic investigation strategies post-presentation when cancer is suspected. They can inform the updating of clinical practice recommendations for specialist referral encompassing a broader range of cancer sites per symptom.
(© 2023. The Author(s).)
Databáze: MEDLINE
Externí odkaz: